Search

Your search keyword '"McGee, L.A."' showing total 189 results

Search Constraints

Start Over You searched for: Author "McGee, L.A." Remove constraint Author: "McGee, L.A."
189 results on '"McGee, L.A."'

Search Results

1. 30-day morbidity and mortality after transoral robotic surgery for human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma: A retrospective analysis of two prospective adjuvant de-escalation trials (MC1273 & MC1675)

2. Patient-specific 3D CT Images Reconstruction from 2D KV Images

5. Physician and Patient-Reported Outcomes of a Phase III Trial of Ultra-Hypofractionated vs. Moderate Hypofractionated Radiotherapy to the Whole Breast after Breast-Conserving Surgery

6. Final Analysis of a Phase III Controlled Randomized Study of Stereotactic Body Proton Therapy or Conventionally Fractionated Proton Therapy for Early Prostate Cancer: PCG GU002

7. Unique T-cell Sub-Population Shifts after SBPT and Nivolumab in Platinum Refractory HNC: Biomarker Correlates from ROR1771

8. ctHPVDNA and Recurrence Risk in MC1675, a Secondary Analysis of a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for HPV Associated Oropharyngeal Squamous Cell Carcinoma

9. A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent Metastatic Head and Neck Cancer: Initial Report of MC ROR1771 Survival Analysis and Toxicity

10. Correlation and Prediction of Modified Barium Swallowing Study with Patient-Reported Outcomes (PROs) for HPV Associated Oropharyngeal Squamous Cell Carcinoma

11. Comparisons of Patient-Reported Quality of Life and Swallowing Scores of Mucosal Sparing Radiation vs. Standard of Care for Oropharyngeal Tumors

12. Patient Reported Outcomes (PROs) in MC1675, De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard of Care Adjuvant Radiation Therapy (SOC) for HPV Associated Oropharyngeal Squamous Cell Carcinoma

13. Ultra-Accelerated Photons, Protons or Brachytherapy for Favorable Early Breast Cancer: Long-Term Results of a 3-Fraction Partial Breast Irradiation Trial

15. Adenoid Cystic Carcinoma of the Head and Neck: Patterns of Recurrence and Implications for Radiotherapy

17. Empirical Relative Biological Effectiveness (RBE) for Mandible Osteoradionecrosis (ORN) in Head and Neck Cancer Patients Treated with Pencil-Beam-Scanning Proton Therapy (PBSPT): A Retrospective, Case-Matched Cohort Study

18. Assessing the Relationship between Residual Cancer Burden and the Tumor Immune-Microenvironment in Early-Stage, Hormone Receptor-Positive Breast Cancer Following Preoperative Radiation Therapy in MC1732 Clinical Trial

19. 30-Day Morbidity and Bleeding Rates Associated with Transoral Robotic Surgery for HPV Associated Oropharyngeal Squamous Cell Carcinoma: A Retrospective Analysis of Two Prospective Adjuvant Radiotherapy Deescalation Trials (MC1273 & MC1675)

20. Non-Inferiority Margin and Nodal Analysis of De-Escalated Adjuvant Radiation Therapy (DART) for HPV-Related Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Preplanned Pooled Analysis of MC1273 & MC1675

21. Speech and Swallowing Function Following De-Escalation Adjuvant Chemoradiotherapy or Standard of Care Adjuvant Therapy for HPV Associated Oropharyngeal Carcinoma: A Prospective Randomized Trial

22. Analysis of Outcomes by Smoking Status in a Phase III Trial of De-Escalated Adjuvant Chemoradiation Therapy in Human Papillomavirus (HPV(+)) Oropharyngeal Squamous Cell Carcinoma (OPSCC)

23. A Prospective Study of Mucosal Sparing Proton Beam Therapy in Resected Oropharyngeal Cancer Patients

24. Hippocampal Sparing Radiotherapy in adults with Primary Brain Tumors: A comparative planning and dosimetric study using IMPT, IMRT and 3DCRT

25. MC1675, a Phase III Evaluation of De-Escalated Adjuvant Radiation Therapy (DART) vs. Standard Adjuvant Treatment for Human Papillomavirus Associated Oropharyngeal Squamous Cell Carcinoma

26. Updated Toxicity and Quality-of-Life Outcomes From a Randomized Phase III Trial of Extreme Hypofractionated vs. Standard Fractionated Proton Therapy for Low-Risk Prostate Cancer

27. MC1635: Randomized Phase III Trial of Hypofractionated Radiotherapy to the Whole Breast After Breast Conserving Surgery

28. Seed Spots Analysis to Characterize Linear Energy Transfer (LET) Effect in the Adverse Event Regions of Head and Neck Cancer Patients Treated by Intensity Modulated Proton Therapy (IMPT)

31. Anaplastic Thyroid Cancer Patterns of Nodal Disease and Proposed Radiotherapy Target Volumes

32. Clinical Outcomes of Histologically Verified Salivary Ductal Carcinomas: Retrospective Analysis of 89 Patients Treated Over 47 Years

33. Comparison of Clinical and Toxicity Outcomes of Adenoid Cystic Carcinomas Treated With Intensity Modulated Radiation Therapy vs. Proton Radiotherapy

34. Oncologic Outcomes for Skin Malignancies of the Head and Neck Treated with Protons, Photons or Electrons

35. Selection of Mediastinal Lymphoma Patients for Proton Therapy in a Prospective Multi-Institutional Registry: Concordance with the ILROG Guidelines

36. A Prospective Study of Mucosal Sparing Proton Beam Therapy in Resected Oropharyngeal Cancer Patients: Toxicity, Quality of Life and Swallow Function

37. Unplanned Implant Removal after Multimodality Therapy for Breast Cancer

38. Patient Reported Outcomes version of the Common Terminology Criteria for Adverse Events and Quality-of-Life Linear Analogue Self-Assessment in Breast Cancer Patients Receiving Radiation Therapy: Single-Institution Prospective Registry

39. Hypofractionation and Dose Effects on Implant Removal after Radiation Therapy for Post-Mastectomy Breast Cancer Patients with Immediate Reconstruction

40. Effect of Common Terminology Criteria for Adverse Events (CTCAE) on Quality-of-Life (QOL) Linear Analogue Self-Assessment (LASA) in Breast Cancer (BC) Patients Receiving Radiation Therapy (RT): Single-Center Prospective Registry Experience

41. Artificial Neural Networks Utilizing Standardly Collected Electronic Healthcare Data Provide Clinically Interpretable Predictions Of Patient-Reported Adverse Events For Breast Cancer

42. Risk Factors for Disease Progression Following Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus–Associated Oropharynx Squamous Cell Carcinoma (HPV-OSCC)

45. Capsular Contracture after Radiation Therapy Following Mastectomy and Implant-Based Reconstruction

46. Patient-Reported Symptomatic Adverse Events (PRO-CTCAE) during Proton and Photon Radiation Therapy: Results of a Prospective Registry of Patient-Reported Outcomes in a Large-Volume, Multi-Site Practice

47. Radiation Therapy Treatment Effect on Overall Survival: Results of a Prospective Registry of Patient-Reported Outcomes in a Large-Volume Multi-Site Practice

48. Comparison of Patient-Reported Outcomes and Acute Toxicities in Oropharyngeal Cancer Patients Treated with VMAT Vs IMPT

Catalog

Books, media, physical & digital resources